Several studies have shown that radiation combined with ICIs or AZD6738 increased the number of TCM cells and prevent tumor recurrence and metastasis.16 27 In our study, compared with radioimmunotherapy, the percentage of TIL CD8+ TCM cells was higher following triple therapy, which may contribute to the delayed tumor recurrence in mice treated with triple therapy. This evidence concerns the gene CD8A and neoplasm.